PMC:7094172 / 12271-12373
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T198 | 71-80 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T82 | 26-27 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T83 | 81-87 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T93 | 66-80 | Chemical | denotes | lead compounds | http://purl.obolibrary.org/obo/CHEBI_33585 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T89 | 0-102 | Sentence | denotes | Table 1 shows that P3 had a favorable therapeutic index among the lead compounds tested in this study. |